DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 213 filers reported holding DEPOMED INC in Q3 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $201,000 | -80.2% | 34,723 | -63.3% | 0.00% | -83.3% |
Q2 2017 | $1,017,000 | +35.4% | 94,649 | +58.2% | 0.01% | +20.0% |
Q1 2017 | $751,000 | +31.3% | 59,816 | +88.5% | 0.01% | +25.0% |
Q4 2016 | $572,000 | -28.5% | 31,731 | -0.9% | 0.00% | -33.3% |
Q3 2016 | $800,000 | +55.0% | 32,031 | +21.9% | 0.01% | +50.0% |
Q2 2016 | $516,000 | +3.6% | 26,281 | -26.6% | 0.00% | 0.0% |
Q1 2016 | $498,000 | -26.3% | 35,781 | -4.0% | 0.00% | -33.3% |
Q4 2015 | $676,000 | -3.8% | 37,281 | 0.0% | 0.01% | -14.3% |
Q3 2015 | $703,000 | -17.5% | 37,281 | -6.0% | 0.01% | -12.5% |
Q2 2015 | $852,000 | -5.3% | 39,681 | -1.2% | 0.01% | -11.1% |
Q1 2015 | $900,000 | +41.1% | 40,181 | +1.5% | 0.01% | +28.6% |
Q4 2014 | $638,000 | +2.4% | 39,591 | -3.4% | 0.01% | -12.5% |
Q3 2014 | $623,000 | +9.3% | 40,991 | 0.0% | 0.01% | +14.3% |
Q2 2014 | $570,000 | -4.0% | 40,991 | 0.0% | 0.01% | -12.5% |
Q1 2014 | $594,000 | +48.1% | 40,991 | +8.0% | 0.01% | +33.3% |
Q4 2013 | $401,000 | – | 37,941 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |